You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RAPP Sale Disclosure
Gault Cheryl · SEC Form 4 · Filed Jul 1, 2026
Sale
Calculated transaction value
$156.96K
Gault Cheryl Chief Operating Officer
RAPP
Rapport Therapeutics
RAPP
Transaction date
Jun 30, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed 1 day later
RAPP daily price context
Close on/before transaction
$41.67
Jun 30, 2026
First close after public filing
$38.97
Jul 2, 2026
30-day return after filing
+5.16%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,792 shares @ $41.39
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-292546
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$415.8K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rapport Therapeutics, Inc. RAPP | Sale | Jun 30, 2026 | $76.17K |
| Rapport Therapeutics, Inc. RAPP Current | Sale | Jun 30, 2026 | $156.96K |
| Rapport Therapeutics, Inc. RAPP | Sale | Jun 30, 2026 | $43.15K |
| Rapport Therapeutics, Inc. RAPP | Sale | Jun 30, 2026 | $139.51K |